ReValve Solutions, Inc. Announces Successful First Human Use of the Transeptal Mitral Valve Replacement

BAINBRIDGE ISLAND, Wash.--(BUSINESS WIRE)--ReValve Solutions, Inc., an innovator in the field of transcatheter structural heart replacement and repair, announced today it has successfully completed the first human use of its transcatheter, Palmetto System for mitral valve replacement. The patient was successfully treated who suffered from severe mitral valve regurgitation and heart failure. The transfemoral-transseptal procedure was performed at the Italian Hospital in Asuncion, Paraguay by Dr.